Clinical Trials in Poland — Country Dashboard | 2,702 EU Studies

Filter these 2,702 trials by condition, phase, sponsor and more.

Open in Search →

2,702 Registered trials

1,005 Recruiting

1,520 Completed trials

692 Sponsors active

1,789 Research sites

Phase III

Phase II

Phase III: 1475 Phase II/III: 128 Phase II: 720 Phase I/II: 91 Phase III/IV: 24 Phase IV: 63 Phase I: 64 Phase I (Other): 79 Phase I (FiH): 45 Other: 13

Oversight events in trials active here:

87 serious breaches 586 temporary halts 52 urgent safety measures 65 unexpected events 112 corrective measures across 331 trials

View oversight register →

Top conditions

Non-small cell lung cancer 82 Non-small cell lung cancer metastatic 35 Crohn's disease 31 Systemic lupus erythematosus 29 Colitis ulcerative 27 Myasthenia gravis 27 Asthma 25 Rheumatoid arthritis 21 Ovarian cancer 20 Diffuse large B-cell lymphoma 19 Multiple sclerosis 19 Breast cancer 17

Top sponsors

Merck Sharp & Dohme LLC 160 AstraZeneca AB 138 F. Hoffmann-La Roche AG 137 Janssen - Cilag International 104 Novartis Pharma AG 79 Pfizer Inc. 65 AbbVie Deutschland GmbH & Co. KG 63 Sanofi-Aventis Recherche & Developpement 63 Bristol-Myers Squibb Services Unlimited Company 59 Amgen Inc. 52 Eli Lilly & Co. 50 Takeda Development Center Americas Inc. 46

Cities with most trials

All 255 cities →

All trials — page 30

2,702 total

A research study looking at how different doses of study medicine (Inno8) work in the body of people with haemophilia A Recruiting

2025-520490-38-00 Phase I (Other) Haemophilia A with or without inhibitors. Proposed indicatio… Novo Nordisk A/S
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and … Recruiting

2024-516652-18-00 Phase III Atherosclerotic cardiovascular disease (ASCVD) and obesity o… Amgen Inc.
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Descartes-08 in Patients With Generalized Myasthenia Gravis (MG) Recruiting

2024-520355-25-00 Phase III generalized myasthenia gravis Cartesian Therapeutics Inc.
Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of NSCLC Recruiting

2024-519883-42-00 Phase III Non-small cell lung cancer Qilu Pharmaceutical Co. Ltd.
An open-label study of JSB462 (luxdegalutamide) in combination with abiraterone in adult male patients with metastatic hormone-sensitive pro… Recruiting

2024-520156-22-00 Phase II Metastatic hormone-sensitive prostate cancer Novartis Pharma AG
Evaluation of the efficacy and safety of prolonged-release budesonide in children with primary IgA nephropathy. Recruiting

2024-518759-45-00 Phase III Children primary nephropathy IgA Medical University Of Warsaw
A Study to Test How Safe, Effective and How the Body Responds to the Combination of Mosunetuzumab and Pirtobrutinib Together to Treat Patien… Recruiting

2024-514152-32-00 Phase I (Other) Relapsed or Refractory Chronic Lymphocytic Leukemia (R/R CLL… F. Hoffmann-La Roche AG
A clinical trial to evaluate efficacy and safety of Xeomin® injections for preventing chronic migraine Recruiting

2024-515682-34-00 Phase III Chronic migraine Merz Therapeutics GmbH
A clinical trial to evaluate efficacy and safety of Xeomin® injections for preventing episodic migraine Recruiting

2024-515715-22-00 Phase III Episodic migraine Merz Therapeutics GmbH
Study of Ruxolitinib Cream in Participants with Hidradenitis Suppurativa (TRuE-HS1) Recruiting

2024-517632-22-00 Phase III Hidradenitis Suppurativa Incyte Corp.
Clinical Randomised Phase 2 Trial of AP31969 versus Placebo for Rhythm Control of Atrial Fibrillation. Recruiting

2025-521377-14-00 Phase II Atrial fibrillation Acesion Pharma ApS
A randomized, phase 3 multicenter study to confirm the clinical efficacy of linaprazan glurate compared to lansoprazole in participants with… Recruiting

2024-518714-31-00 Phase III Erosive esophagitis (EE) due to gastroesophageal reflux dise… Cinclus Pharma Holding AB (publ)
A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab vs Chemotherapy plus Pembrolizumab as First-Line Treatment o… Recruiting

2023-508056-19-00 Phase III HER2-Expressing (IHC 3+/IHC 2+), Mismatch Repair Proficient… AstraZeneca AB
Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Platinum Resistant Ovarian Cancer Recruiting

2024-514822-21-00 Phase III Platinum-resistant Ovarian Cancer Genmab A/S
A Phase 3, randomized, parallel-group, double-blind, multicenter study investigating the safety and efficacy of NT 201 compared with placebo… Recruiting

2025-520499-24-00 Phase III Moderate to Severe Platysma Prominence Merz Aesthetics GmbH
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age with Moderate-to-Severe Atopic Eczema Recruiting

2023-509121-51-00 Phase III Moderate-to-Severe Atopic Dermatitis Pfizer Inc.
A study to learn about nadofaragene firadenovec given alone or together with gemcitabine and docetaxel or, pembrolizumab in adults with non-… Recruiting

2024-512177-27-01 Phase III High-risk Bacillus Calmette-Guerin (BCG)-unresponsive non-mu… Ferring Pharmaceuticals A/S
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-to-Severe Asthma Recruiting

2024-517866-40-00 Phase II Moderate-to-severe Asthma Pfizer Inc.
A clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008) Recruiting

2024-518296-56-00 Phase III Crohn’s Disease Merck Sharp & Dohme LLC
A study to learn about the efficacy and safety of 4P004 in participants with knee synovitis and osteoarthritis Recruiting

2024-518916-38-00 Phase II knee synovitis and osteoarthritis 4moving Biotech
A study to investigate the effect of AZD6793 in participants with moderate to very severe chronic obstructive pulmonary disease Recruiting

2025-520473-40-00 Phase II Moderate to Very Severe Chronic Obstructive Pulmonary Diseas… AstraZeneca AB
A study to investigate efficacy and safety of brivekimig in participants with Crohn’s disease Recruiting

2024-517016-30-00 Phase II Crohn’s disease Sanofi-Aventis Recherche & Developpement
A clinical study of MK-1084 with targeted therapy and chemotherapy in people with colorectal cancer (MK-1084-012). Recruiting

2024-517232-22-00 Phase III KRAS G12C-mutant, Locally Advanced Unresectable or Metastati… Merck Sharp & Dohme LLC
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen Recruiting

2024-519875-24-00 Phase III Carcinoid syndrome Crinetics Pharmaceuticals Inc.

Showing 697–720 of 2,702 trials

← All countries